Breaking News Instant updates and real-time market news.

AGN

Allergan

$235.83

0.05 (0.02%)

15:00
10/05/16
10/05
15:00
10/05/16
15:00

Customer lays out $5.5M for Allergan call spread

Customer lays out $5.5M for Allergan call spread. Tied to a hedge of 231K shares at $236 a customer paid $5.05 for 11K Jan 255/280 call spreads on the PHLX. Both option legs open new positions suggesting a bullish view for shares into 2017.

  • 06

    Nov

AGN Allergan
$235.83

0.05 (0.02%)

09/21/16
CANT
09/21/16
DOWNGRADE
CANT
Hold
Tobira Therapeutics downgraded to Hold from Buy at Cantor
Cantor analyst Elemer Piros downgraded Tobira (TBRA) after the company agreed to be acquired by Allergan (AGN). Target to $42 from $19.
09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

SWKS

Skyworks

$104.20

1.23 (1.19%)

, SSNLF

Samsung

10:09
04/28/17
04/28
10:09
04/28/17
10:09
Recommendations
Skyworks, Samsung analyst commentary  »

Skyworks price target…

SWKS

Skyworks

$104.20

1.23 (1.19%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 30

    May

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:07
04/28/17
04/28
10:07
04/28/17
10:07
Hot Stocks
Radius Health jumps after FDA posts approval of Tymlos 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

ORLY

O'Reilly Automotive

$257.19

-7.88 (-2.97%)

10:02
04/28/17
04/28
10:02
04/28/17
10:02
Recommendations
O'Reilly Automotive analyst commentary  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

MHK

Mohawk

$229.91

-8.97 (-3.76%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Technical Analysis
Mohawk testing uptrend support line following earnings »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

10:01
04/28/17
04/28
10:01
04/28/17
10:01
General news
Consumer Sentiment Index data reported »

April Consumer Sentiment…

CL

Colgate-Palmolive

$72.10

-1.2 (-1.64%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Options
Call buyer in Colgate as shares fall on earnings »

Call buyer in Colgate as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

EEX

Emerald Expositions Events

10:00
04/28/17
04/28
10:00
04/28/17
10:00
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

IVC

Invacare

$14.85

1.6 (12.08%)

09:59
04/28/17
04/28
09:59
04/28/17
09:59
Upgrade
Invacare rating change  »

Invacare upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 18

    May

CVNA

Carvana

09:58
04/28/17
04/28
09:58
04/28/17
09:58
Syndicate
Breaking Syndicate news story on Carvana »

Carvana opens at $13.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

EFX

Equifax

$134.84

-1.35 (-0.99%)

09:56
04/28/17
04/28
09:56
04/28/17
09:56
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

EEX

Emerald Expositions Events

09:55
04/28/17
04/28
09:55
04/28/17
09:55
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:55
04/28/17
04/28
09:55
04/28/17
09:55
General news
U.S. Chicago PMI increased 0.6 points to 58.3 in April »

U.S. Chicago PMI…

CSGP

CoStar Group

$236.71

17.35 (7.91%)

09:53
04/28/17
04/28
09:53
04/28/17
09:53
Recommendations
CoStar Group analyst commentary  »

CoStar Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

BOKF

BOK Financial

$85.04

-0.42 (-0.49%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Upgrade
BOK Financial rating change  »

BOK Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

OCLR

Oclaro

$7.93

0.01 (0.13%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Recommendations
Oclaro analyst commentary  »

Oclaro estimates lowered …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

BSX

Boston Scientific

$26.16

-0.02 (-0.08%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Options
Active trading in Boston Scientific short-term calls »

Active trading in Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

EEX

Emerald Expositions Events

09:50
04/28/17
04/28
09:50
04/28/17
09:50
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:50
04/28/17
04/28
09:50
04/28/17
09:50
General news
The hefty 0.8% U.S. Q1 ECI gain »

The hefty 0.8% U.S. Q1…

ZYME

Zymeworks

09:49
04/28/17
04/28
09:49
04/28/17
09:49
Syndicate
Breaking Syndicate news story on Zymeworks »

Zymeworks opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

XRF

China Rapid Finance

09:48
04/28/17
04/28
09:48
04/28/17
09:48
Syndicate
Breaking Syndicate news story on China Rapid Finance »

China Rapid Finance opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ALGN

Align Technology

$120.09

0.35 (0.29%)

09:48
04/28/17
04/28
09:48
04/28/17
09:48
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CVNA

Carvana

09:47
04/28/17
04/28
09:47
04/28/17
09:47
Syndicate
Breaking Syndicate news story on Carvana »

Carvana IPO indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CLDR

Cloudera

09:47
04/28/17
04/28
09:47
04/28/17
09:47
Syndicate
Cloudera IPO indicated to open at $14 on 1.3M shares »

Cloudera (CLDR) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:46
04/28/17
04/28
09:46
04/28/17
09:46
General news
Chicago PMI Business Barometer Index data reported »

April Chicago PMI…

09:45
04/28/17
04/28
09:45
04/28/17
09:45
General news
U. Michigan sentiment preview: »

U. Michigan sentiment…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.